BR112014012759A8 - composto, composição e método para tratamento - Google Patents
composto, composição e método para tratamentoInfo
- Publication number
- BR112014012759A8 BR112014012759A8 BR112014012759A BR112014012759A BR112014012759A8 BR 112014012759 A8 BR112014012759 A8 BR 112014012759A8 BR 112014012759 A BR112014012759 A BR 112014012759A BR 112014012759 A BR112014012759 A BR 112014012759A BR 112014012759 A8 BR112014012759 A8 BR 112014012759A8
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- treatment
- composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161563926P | 2011-11-28 | 2011-11-28 | |
| PCT/US2012/063802 WO2013081783A1 (en) | 2011-11-28 | 2012-11-07 | N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014012759A2 BR112014012759A2 (pt) | 2017-06-13 |
| BR112014012759A8 true BR112014012759A8 (pt) | 2017-06-20 |
Family
ID=47179004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014012759A BR112014012759A8 (pt) | 2011-11-28 | 2012-11-07 | composto, composição e método para tratamento |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20140315857A1 (pt) |
| EP (1) | EP2785694A1 (pt) |
| JP (1) | JP2015502936A (pt) |
| KR (1) | KR20140094026A (pt) |
| CN (1) | CN103958476A (pt) |
| AR (1) | AR089014A1 (pt) |
| AU (1) | AU2012346433A1 (pt) |
| BR (1) | BR112014012759A8 (pt) |
| CA (1) | CA2855001A1 (pt) |
| CL (1) | CL2014001377A1 (pt) |
| CO (1) | CO6980661A2 (pt) |
| IL (1) | IL232404A0 (pt) |
| MA (1) | MA35742B1 (pt) |
| MX (1) | MX2014006317A (pt) |
| PH (1) | PH12014501181A1 (pt) |
| RU (1) | RU2014126367A (pt) |
| SG (1) | SG11201402664VA (pt) |
| TN (1) | TN2014000166A1 (pt) |
| TW (1) | TW201326128A (pt) |
| WO (1) | WO2013081783A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014065411A1 (ja) * | 2012-10-26 | 2014-05-01 | 株式会社エス・ディー・エス バイオテック | 農園芸用の有害生物防除剤としてのスルホンアミド誘導体 |
| WO2014099837A1 (en) * | 2012-12-18 | 2014-06-26 | E. I. Du Pont De Nemours And Company | Sulfonamide anthelmintics |
| BR112019009529A2 (pt) * | 2016-11-11 | 2019-07-30 | Bayer Animal Health Gmbh | novos derivados de quinolina |
| BR112019028181A2 (pt) * | 2017-06-30 | 2020-07-07 | Bayer Animal Health Gmbh | novos derivados de azaquinolina |
| US20240148744A1 (en) * | 2021-02-09 | 2024-05-09 | Celgene Corporation | Sulfonamides and their use for treatment of helminthic infections and diseases |
| WO2023122212A2 (en) | 2021-12-21 | 2023-06-29 | Southern Research Institute | Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of sars virus |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1815604A (en) | 1922-10-31 | 1931-07-21 | Winthrop Chem Co | Organic mercury compound |
| US1679404A (en) | 1926-02-04 | 1928-08-07 | Rockwood Sprinkler Co Massachusetts | Constant-alarm device for alarm valves |
| US1959705A (en) | 1931-08-12 | 1934-05-22 | Standard Steel Car Corp | Car door |
| US5299582A (en) | 1991-09-16 | 1994-04-05 | Little Rapids Corporation | Surgical isolation apparatus |
| US5399582A (en) | 1993-11-01 | 1995-03-21 | Merck & Co., Inc. | Antiparasitic agents |
| US5962499A (en) | 1995-03-20 | 1999-10-05 | Merck & Co., Inc. | Nodulisporic acid derivatives |
| US6221894B1 (en) | 1995-03-20 | 2001-04-24 | Merck & Co., Inc. | Nodulisporic acid derivatives |
| US5595991A (en) | 1995-03-20 | 1997-01-21 | Merck & Co., Inc. | Anthelmintic use of nodulisporic acid and analogs thereof |
| PL185563B1 (pl) | 1995-03-20 | 2003-06-30 | Merck & Co Inc | Pochodne kwasu nodulisporowego oraz zawierające je kompozycje farmaceutyczne |
| US5958888A (en) | 1996-07-02 | 1999-09-28 | Merial, Inc. | Water miscible macrolide solutions |
| US6271255B1 (en) | 1996-07-05 | 2001-08-07 | Biotica Technology Limited | Erythromycins and process for their preparation |
| US5834260A (en) | 1996-08-30 | 1998-11-10 | Merck & Co., Inc. | Antiparasitic agents |
| US6339063B1 (en) | 1997-09-10 | 2002-01-15 | Merck & Co., Inc. | 9a-azalides as veterinary antimicrobial agents |
| JP2003512290A (ja) | 1997-09-10 | 2003-04-02 | メルク エンド カムパニー インコーポレーテッド | 家畜抗菌剤としての８ａ−アザライド |
| AP9801420A0 (en) | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
| US6136838A (en) | 1998-03-19 | 2000-10-24 | Merck & Co., Inc. | Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations |
| US6239112B1 (en) | 1998-07-09 | 2001-05-29 | Merial, Inc. | Water miscible macrolide solutions |
| CA2292359C (en) | 1999-01-28 | 2004-09-28 | Pfizer Products Inc. | Novel azalides and methods of making same |
| NZ518665A (en) | 2000-01-27 | 2005-02-25 | Pfizer Prod Inc | Azalide antibiotic compositions |
| US6399796B2 (en) | 2000-03-17 | 2002-06-04 | Roche Vitamins Inc. | Activation of a Diels-Alder reaction of a sterol 5,7-diene |
| CN1649829A (zh) | 2002-03-08 | 2005-08-03 | 先灵-普劳有限公司 | 新型氟苯尼考类抗生素 |
| AU2004278095B2 (en) * | 2003-09-18 | 2010-06-24 | Basf Se | 4-piridinylmethylsulphonamide derivatives as fungicidal plant protection agents |
| CN100579532C (zh) | 2003-12-23 | 2010-01-13 | 先灵-普劳有限公司 | 具有改善水溶性的氟苯尼考前药 |
| NZ548098A (en) | 2003-12-31 | 2010-05-28 | Schering Plough Ltd | Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives |
| US7361689B2 (en) | 2003-12-31 | 2008-04-22 | Schering-Plough Animal Health Corporation | Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof |
| EP1571150A1 (en) | 2004-03-02 | 2005-09-07 | Aventis Pharma Deutschland GmbH | Process for the preparation of tryptase inhibitors |
| MX2007003378A (es) | 2004-09-23 | 2007-05-10 | Schering Plough Ltd | Control de parasitos en animales mediante el uso de nuevos derivados de trifluorometansulfonanilida oxima eter. |
| US7642391B1 (en) | 2005-03-04 | 2010-01-05 | Iowa State University Research Foundation, Inc. | Palladium-catalyzed coupling of aryl halides with alkynes |
| CN101247722A (zh) | 2005-03-16 | 2008-08-20 | 巴斯福股份公司 | 用于对抗节肢动物门害虫的n-(4-吡啶基)甲基磺酰胺 |
| JP2008545788A (ja) | 2005-06-09 | 2008-12-18 | シェーリング−プラウ・リミテッド | Ｎ−［（フェニルオキシ）フェニル］−１，１，１−トリフルオロメタンスルホンアミドおよびｎ−［（フェニルスルファニル）フェニル）］−１，１，１−トリフルオロメタンスルホンアミド誘導体による動物中の寄生生物の制御 |
| US20070285554A1 (en) | 2005-10-31 | 2007-12-13 | Dor Givon | Apparatus method and system for imaging |
| JP2009526775A (ja) * | 2006-02-14 | 2009-07-23 | ビーエーエスエフ ソシエタス・ヨーロピア | ピリジン−４−イルメチルアミド |
| CA2645069A1 (en) * | 2006-03-15 | 2007-09-20 | Basf Se | Quinoline derivatives and their use as pesticides |
| BRPI0713502A2 (pt) | 2006-06-20 | 2012-03-13 | F. Hoffmann-La Roche Ag | derivados de tetralina de arilsulfonamidil e empregos destes |
| CA2656875C (en) | 2006-07-11 | 2011-09-06 | Pfizer Inc. | Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| CA2662021A1 (en) * | 2006-09-12 | 2008-03-20 | Basf Se | Quinolinylmethyl compounds |
| WO2008079292A1 (en) | 2006-12-20 | 2008-07-03 | Amgen Inc. | Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer |
| WO2008090434A1 (en) | 2007-01-25 | 2008-07-31 | Pfizer Japan Inc. | Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| TWI482771B (zh) * | 2009-05-04 | 2015-05-01 | Du Pont | 磺醯胺殺線蟲劑 |
| CN103619818A (zh) * | 2011-06-20 | 2014-03-05 | 纳幕尔杜邦公司 | 用于治疗蠕虫感染的杂环化合物 |
-
2012
- 2012-11-07 AU AU2012346433A patent/AU2012346433A1/en not_active Abandoned
- 2012-11-07 JP JP2014543484A patent/JP2015502936A/ja active Pending
- 2012-11-07 CN CN201280058467.0A patent/CN103958476A/zh active Pending
- 2012-11-07 CA CA2855001A patent/CA2855001A1/en not_active Abandoned
- 2012-11-07 TW TW101141259A patent/TW201326128A/zh unknown
- 2012-11-07 KR KR1020147017532A patent/KR20140094026A/ko not_active Application Discontinuation
- 2012-11-07 WO PCT/US2012/063802 patent/WO2013081783A1/en active Application Filing
- 2012-11-07 MX MX2014006317A patent/MX2014006317A/es unknown
- 2012-11-07 SG SG11201402664VA patent/SG11201402664VA/en unknown
- 2012-11-07 US US14/358,196 patent/US20140315857A1/en not_active Abandoned
- 2012-11-07 EP EP12787321.4A patent/EP2785694A1/en not_active Withdrawn
- 2012-11-07 RU RU2014126367A patent/RU2014126367A/ru unknown
- 2012-11-07 BR BR112014012759A patent/BR112014012759A8/pt not_active Application Discontinuation
- 2012-11-28 AR ARP120104468A patent/AR089014A1/es unknown
-
2014
- 2014-04-18 TN TNP2014000166A patent/TN2014000166A1/en unknown
- 2014-05-01 IL IL232404A patent/IL232404A0/en unknown
- 2014-05-26 PH PH12014501181A patent/PH12014501181A1/en unknown
- 2014-05-26 CL CL2014001377A patent/CL2014001377A1/es unknown
- 2014-06-10 CO CO14125212A patent/CO6980661A2/es unknown
- 2014-06-23 MA MA37145A patent/MA35742B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140094026A (ko) | 2014-07-29 |
| AR089014A1 (es) | 2014-07-23 |
| RU2014126367A (ru) | 2016-01-27 |
| JP2015502936A (ja) | 2015-01-29 |
| BR112014012759A2 (pt) | 2017-06-13 |
| SG11201402664VA (en) | 2014-06-27 |
| CL2014001377A1 (es) | 2014-10-17 |
| TN2014000166A1 (en) | 2015-09-30 |
| IL232404A0 (en) | 2014-06-30 |
| PH12014501181A1 (en) | 2014-09-08 |
| CO6980661A2 (es) | 2014-06-27 |
| AU2012346433A1 (en) | 2014-05-08 |
| WO2013081783A1 (en) | 2013-06-06 |
| TW201326128A (zh) | 2013-07-01 |
| CA2855001A1 (en) | 2013-06-06 |
| MX2014006317A (es) | 2014-06-23 |
| US20140315857A1 (en) | 2014-10-23 |
| CN103958476A (zh) | 2014-07-30 |
| MA35742B1 (fr) | 2014-12-01 |
| EP2785694A1 (en) | 2014-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6930366A2 (es) | Método para el tratamiento de vhc | |
| BR112014013246A8 (pt) | composição catalisadora, e, método para tratar nox | |
| BR112013009935A2 (pt) | compostos, composição, método e semente tratada | |
| BR112013019732A2 (pt) | composições e métodos para tratamento de doenças cardiovasculares | |
| CO6960110A1 (es) | Composición aditiva para fluidos de tratamiento de pozos | |
| BR112014009528A2 (pt) | métodos e composições para tratar eritropoiese ineficaz | |
| BR112013010725A2 (pt) | método, e, composição | |
| BR112013007678A2 (pt) | método para tratamento de doenças alérgicas | |
| BR112014003798A2 (pt) | método para fabricar um composto, e, composto | |
| BR112014007619A2 (pt) | composição cosmética, e, método para melhorar pelo menos uma propriedade | |
| CO6890100A2 (es) | Tratamientos de combinación para hepatitis c | |
| BRPI1013878A2 (pt) | método para tratar distúrbios metabólicos, e, composto | |
| BR112013032225A2 (pt) | método para purificar toxina de difteria, e, formulação | |
| BR112014010450A2 (pt) | composição e método | |
| BR112014004192A2 (pt) | composição de tratamento de sementes, e, método de tratamento de sementes | |
| BR112013018679A2 (pt) | agente para o tratamento da alopecia | |
| BR112013016491A2 (pt) | método para tratamento de têxtil | |
| BR112014031896A2 (pt) | composto, composição farmacêutica, e, método para o tratamento de um distúrbio | |
| BR112014029531A2 (pt) | composto de piridina, composição e método para controlar vegetação indesejada | |
| BR112013022306A2 (pt) | método, e, composição | |
| BR112013022820A2 (pt) | método de tratamento | |
| BR112014031899A8 (pt) | composto, composição farmacêutica, e, método para tratamento de um distúrbio | |
| BR112014031512A2 (pt) | composição cosmética e método para o tratamento cosmético. | |
| BR112014004414A2 (pt) | composições e métodos para tratar doença neurodegenerativa | |
| BR112014014285A2 (pt) | composição, e, método para fabricar uma composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |